| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |